Mycolixin Powder
Natural health product licensed in Canada
- Other names
- Mycodicin Powder
- Licence holder
- Partenaris Inc.
- NPN or DIN-HM
- 80042875
- Status
- Inactive licence
- Licence date
- 17 June 2013
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Topique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Sel de sodium d'acide carbonique (1:1) Source : Bicarbonate de sodium | 350 mg/g |
| Arthrospira maxima Source : En entier | 43.5 mg/g |
Non-medicinal ingredients
Talc
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 0.25 Cuillère à thé | 1 day |
| Adolescentes | minimum: 12 years ; maximum: 17 years | 0.25 Cuillère à thé | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Could provide symptomatic relief of fungal skin infections of the feet.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80042875
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.